David T Doherty insider trades: Surgery Partners (SGRY) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
19 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | SGRY | ↓ Sell | 8,867 | $12.50 | $111K | Direct | Mar 16, 2026 (0d) |
| Mar 6, 2026 | SGRY | ↓ Sell | 14,574 | $13.84 | $202K | Direct | Mar 9, 2026 (3d) |
| Aug 8, 2025 | SGRY | ↓ Sell | 47,491 | $23.39 | $1.1M | Direct | Aug 8, 2025 (0d) |
| Mar 10, 2025 | SGRY | ↓ Sell | 6,733 | $24.02 | $162K | Direct | Mar 13, 2025 (3d) |
| Feb 7, 2025 | SGRY | ↓ Sell | 13,641 | $25.61 | $349K | Direct | Feb 10, 2025 (3d) |
| Mar 14, 2024 | SGRY | ↓ Sell | 721 | $28.59 | $21K | Direct | Mar 15, 2024 (1d) |
| Mar 4, 2024 | SGRY | ↓ Sell | 3,426 | $30.37 | $104K | Direct | Mar 6, 2024 (2d) |
| Feb 12, 2024 | SGRY | ↓ Sell | 1,020 | $34.93 | $36K | Direct | Feb 14, 2024 (2d) |
| Feb 2, 2024 | SGRY | ↓ Sell | 2,306 | $31.89 | $74K | Direct | Feb 6, 2024 (4d) |
| Aug 30, 2023 | SGRY | ↓ Sell | 2,202 | $36.04 | $79K | Direct | Sep 1, 2023 (2d) |
| Mar 15, 2023 | SGRY | ↓ Sell | 3,372 | $30.85 | $104K | Direct | Mar 15, 2023 (0d) |
| Mar 3, 2023 | SGRY | ↓ Sell | 20,000 | $33.98 | $680K | Direct | Mar 6, 2023 (3d) |
| Feb 27, 2023 | SGRY | ↓ Sell | 4,315 | $33.53 | $145K | Direct | Mar 1, 2023 (2d) |
| Feb 13, 2023 | SGRY | ↓ Sell | 942 | $33.92 | $32K | Direct | Feb 15, 2023 (2d) |
| Feb 2, 2023 | SGRY | ↓ Sell | 1,947 | $35.90 | $70K | Direct | Feb 6, 2023 (4d) |
| Aug 30, 2022 | SGRY | ↓ Sell | 171 | $29.65 | $5K | Direct | Aug 31, 2022 (1d) |
| Mar 16, 2022 | SGRY | ↓ Sell | 4,769 | $49.66 | $237K | Direct | Mar 17, 2022 (1d) |
| Mar 11, 2022 | SGRY | ↓ Sell | 376 | $54.69 | $21K | Direct | Mar 14, 2022 (3d) |
| Feb 25, 2022 | SGRY | ↓ Sell | 2,221 | $50.48 | $112K | Direct | Mar 2, 2022 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SGRY insiders
Open-market trades in the last 12 months
About David T Doherty's insider trades
David T Doherty is Chief Financial Officer at Surgery Partners (SGRY). Since Feb 25, 2022, David has reported no open-market purchases and 19 sales worth $3.7M on SEC Form 4. In the last 12 months: 2 sales ($313K).
Their filings also include grants and awards (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SGRY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.